BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1829794)

  • 1. Morphometric analysis of the prefrontal cortex in Huntington's disease.
    Sotrel A; Paskevich PA; Kiely DK; Bird ED; Williams RS; Myers RH
    Neurology; 1991 Jul; 41(7):1117-23. PubMed ID: 1829794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuronal loss in layers V and VI of cerebral cortex in Huntington's disease.
    Hedreen JC; Peyser CE; Folstein SE; Ross CA
    Neurosci Lett; 1991 Dec; 133(2):257-61. PubMed ID: 1840078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for progression in frontal cortical pathology in late-stage Huntington's disease.
    Selemon LD; Rajkowska G; Goldman-Rakic PS
    J Comp Neurol; 2004 Jan; 468(2):190-204. PubMed ID: 14648679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for neuronal degeneration and dendritic plasticity in cortical pyramidal neurons of Huntington's disease: a quantitative Golgi study.
    Sotrel A; Williams RS; Kaufmann WE; Myers RH
    Neurology; 1993 Oct; 43(10):2088-96. PubMed ID: 8413971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortical and striatal neurone number in Huntington's disease.
    Heinsen H; Strik M; Bauer M; Luther K; Ulmar G; Gangnus D; Jungkunz G; Eisenmenger W; Götz M
    Acta Neuropathol; 1994; 88(4):320-33. PubMed ID: 7839825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Widespread heterogeneous neuronal loss across the cerebral cortex in Huntington's disease.
    Nana AL; Kim EH; Thu DC; Oorschot DE; Tippett LJ; Hogg VM; Synek BJ; Roxburgh R; Waldvogel HJ; Faull RL
    J Huntingtons Dis; 2014; 3(1):45-64. PubMed ID: 25062764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased neuronal and increased oligodendroglial densities in Huntington's disease caudate nucleus.
    Myers RH; Vonsattel JP; Paskevich PA; Kiely DK; Stevens TJ; Cupples LA; Richardson EP; Bird ED
    J Neuropathol Exp Neurol; 1991 Nov; 50(6):729-42. PubMed ID: 1836225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated neuronal density in prefrontal area 46 in brains from schizophrenic patients: application of a three-dimensional, stereologic counting method.
    Selemon LD; Rajkowska G; Goldman-Rakic PS
    J Comp Neurol; 1998 Mar; 392(3):402-12. PubMed ID: 9511926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyramidal cell loss in motor cortices in Huntington's disease.
    Macdonald V; Halliday G
    Neurobiol Dis; 2002 Aug; 10(3):378-86. PubMed ID: 12270698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell loss in the motor and cingulate cortex correlates with symptomatology in Huntington's disease.
    Thu DC; Oorschot DE; Tippett LJ; Nana AL; Hogg VM; Synek BJ; Luthi-Carter R; Waldvogel HJ; Faull RL
    Brain; 2010 Apr; 133(Pt 4):1094-110. PubMed ID: 20375136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significant loss of pyramidal neurons in the angular gyrus of patients with Huntington's disease.
    Macdonald V; Halliday GM; Trent RJ; McCusker EA
    Neuropathol Appl Neurobiol; 1997 Dec; 23(6):492-5. PubMed ID: 9460715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A quantitative investigation of the substantia nigra in Huntington's disease.
    Oyanagi K; Takeda S; Takahashi H; Ohama E; Ikuta F
    Ann Neurol; 1989 Jul; 26(1):13-9. PubMed ID: 2528318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear membrane indentations in Huntington's chorea.
    Roos RA; Bots GT
    J Neurol Sci; 1983 Sep; 61(1):37-47. PubMed ID: 6226764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3-Nitropropionic acid neurotoxicity: visualization by silver staining and implications for use as an animal model of Huntington's disease.
    Miller PJ; Zaborszky L
    Exp Neurol; 1997 Jul; 146(1):212-29. PubMed ID: 9225755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in cortical thickness in the frontal lobes in schizophrenia are a result of thinning of pyramidal cell layers.
    Williams MR; Chaudhry R; Perera S; Pearce RK; Hirsch SR; Ansorge O; Thom M; Maier M
    Eur Arch Psychiatry Clin Neurosci; 2013 Feb; 263(1):25-39. PubMed ID: 22610045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Huntington's Disease (HD): Neurodegeneration of Brodmann's Primary Visual Area 17 (BA17).
    Rüb U; Seidel K; Vonsattel JP; Lange HW; Eisenmenger W; Götz M; Del Turco D; Bouzrou M; Korf HW; Heinsen H
    Brain Pathol; 2015 Nov; 25(6):701-11. PubMed ID: 25495445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17.
    Selemon LD; Rajkowska G; Goldman-Rakic PS
    Arch Gen Psychiatry; 1995 Oct; 52(10):805-18; discussion 819-20. PubMed ID: 7575100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Quantitative and cytomorphometric analysis of glial population in the frontal cortex of contralaterally lesioned rats].
    Ramírez-Expósito MJ; Martínez-Martos JM
    Rev Neurol; 1999 Sep 1-15; 29(5):396-403. PubMed ID: 10584240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early changes in Huntington's disease patient brains involve alterations in cytoskeletal and synaptic elements.
    DiProspero NA; Chen EY; Charles V; Plomann M; Kordower JH; Tagle DA
    J Neurocytol; 2004 Sep; 33(5):517-33. PubMed ID: 15906159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lowered oligodendroglial cell density in the prefrontal cortex in schizophrenia].
    Vostrikov VM; Uranova NA; Rakhmanova VI; Orlovskaia DD
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(1):47-51. PubMed ID: 14870693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.